Download Genetic Control ms

Survey
yes no Was this document useful for you?
   Thank you for your participation!

* Your assessment is very important for improving the workof artificial intelligence, which forms the content of this project

Document related concepts

Butyric acid wikipedia , lookup

Enzyme wikipedia , lookup

Cre-Lox recombination wikipedia , lookup

Protein wikipedia , lookup

Protein (nutrient) wikipedia , lookup

Molecular evolution wikipedia , lookup

Deoxyribozyme wikipedia , lookup

Artificial gene synthesis wikipedia , lookup

List of types of proteins wikipedia , lookup

Peptide synthesis wikipedia , lookup

Metalloprotein wikipedia , lookup

Bottromycin wikipedia , lookup

Proteolysis wikipedia , lookup

Cell-penetrating peptide wikipedia , lookup

Metabolism wikipedia , lookup

Protein structure prediction wikipedia , lookup

Nucleic acid analogue wikipedia , lookup

Transfer RNA wikipedia , lookup

Biochemistry wikipedia , lookup

Genetic code wikipedia , lookup

Expanded genetic code wikipedia , lookup

Transcript
Year 12 AS Level Past Paper Genetic Control Mark Scheme
1.
(a) (i) U - phosphate / PO4; R phosphoric acid / phosphorus / P
W - deoxyribose; R pentose
X - cytosine; R nitrogenous base / pyrimidine / C 3
(ii) Z - hydrogen; R H 1
(b) Assume answer is about polypeptide unless indicated otherwise.
A comparison is not required. Information given below is for either polypeptide or DNA
features.
A ideas from either column.
Do not penalise if points are not corresponding on one line /sentence. Mark all points on
line. Only R if biologically incorrect.
polypeptide DNA, amino acids nucleotides ;
one / single strand / chain two / double strand / chains ;
peptide bonds phosphodiester ;
R between peptides /polypeptides
20 monomers / sub units only 4 monomers / sub units ;
A > 4 monomers / sub units R 4 bases
no phosphate / PO4 has phosphate / PO4 ;
2o / 3o structure double helix ; 3 max
[Total: 7]
2.
a)
W cytosine;
X deoxyribose;
Y nucleotide (triphosphate); [3]
(b) base pairing/A-T and C-G; A purine - pyrimidine
ref to complementary/explained with ref to H bonds; R complementary in wrong context
(free) nucleotides pair with both, strands/each strand/polynucleotides/sides;
both strands act as templates;
to produce two DNA molecules that are identical to one another; [max 3]
(c) (all nuclei/cells) are genetically identical; A genetic stability, same genetic
information, exact genetic material, genetic material does not vary, same genotype;
no mutation;
any consequence of mutation;
e.g. cells not recognised, cells divide uncontrollably, substitution of 1 amino acid results
in disease e.g. sickle cell anaemia, enzyme’s active site altered, forms different protein
with different function. [max 2]
[Total: 8]
3.
(a) one mark per row
[5]
(b) CAG; [1]
(c) tRNA, combines with amino acid / carries amino acid to ribosome;
idea of specificity; e.g. each type of tRNA is specific to an amino acid anticodon matches
amino acid idea;
example from Fig. 3.1;
codon on messenger RNA pairs with anticodon on tRNA;
example from Fig. 3.1;
two sites on ribosome;
further detail; e.g. P and A site (and E)
leave ribosome after amino acid joins polypeptide;
continually reused; [max 5]
(d) variable region;
binding region to antigen;
shape is specific to, choleragen / antigen;
complementary;
ref to R groups on amino acids (in polypeptide / protein);
different, sequences of amino acids / primary structures;
ref to, folding of the molecule / secondary structure / tertiary structure; [max 3]
(e) poor sanitation / no treatment of faecal waste;
contamination of (drinking) water supply;
poverty / poor living conditions / poor hygiene / poor (health) education;
ref to natural disasters; e.g. assistance / aid / medical help / AW, cannot arrive in time
no rehydration therapy available (at time when needed);
no (effective) vaccine;
further detail; (bacteria live in gut, where immune system is not effective) [max 3]
[Total: 17]
4.
(a) (i) tertiary (structure) ; A 3o [1]
(ii) secondary (structure) ; A 2o , alpha / α, helix [1]
(b) active site ; A catalytic site [1]
(c) (i) mRNA CGU ; UGC / UGU GAA;
DNA GCA ACG / ACA CTT ; [3]
(ii) many / several / more than one, triplet for each amino acid ; A codon
an e.g. from Table 3.1 ;
degenerate code / description e.g. 64 possible triplets for 20 amino acids ; A codons
AVP ; e.g. may be an intron in this region, different nucleotides at the beginning
(signal sequence) [2 max]
(d) (i) reject references to time e.g. rapid, slowly
as the concentration of, enzyme / lysozyme, increases the percentage of
bacteria surviving decreases / AW ; R if only 1 named
steep, decline / decrease, 0 to 10 / first two concentrations, for E. coli ;
A large percentage difference in E.coli surviving at 0 to 10 / first two concentrations
less steep / more gradual, decline / decrease, from 10 to 150 for E. coli ;
decline / decrease, shallower / less steep from 0 – ,40 / 60 / 70 / 80, for S. aureus ;
A small percentage difference in S. aureus surviving from 0 – , 60 / 70 / 80
decline / decrease, more significant / steeper / more abrupt, from 60 / 70 / 80, up to
150 for S. aureus ; A large percentage difference in S.aureus surviving from 60 / 70 /
80, up to 150 always more S. aureus than E. coli ; ora
all bacteria survive with no lysozyme ;
lysozyme is more effective, at killing / against, E. coli / AW ; A ora
all E. coli killed, at 150 pmol dm-3 (of lysozyme) / at highest concentration ;
comparative data quote ; both axes, both curves
comparative data quote ; penalise once for lack of units in both [4 max]
(ii) different, polysaccharides / peptidoglycans, in cell walls ;
S. aureus, does not have / has less, polysaccharides / peptidoglycans, in cell wall ;
ref to shape of active site ;
ref to shape of, polysaccharide / peptidoglycan (to fit into active site) ;
S. aureus has a capsule / ora ; A protective lipids
AVP ; e.g. S. aureus produces inhibitor [2 max]
[Total: 14]